CreoSG

크레오에스지 · 040350

Information Technology IT Services · KOSDAQ

Small-cap

Market cap US$87M (₩120.1B)

Overview

CreoSG supplies core banking software, the systems that run a bank's fundamental daily operations, to banks and other financial institutions in South Korea, and also provides IT consulting, system maintenance, and legacy-system migration services to clients in automotive, apparel, and paper industries.

Its software product, BANCS-K, is its primary offering in the solutions division. Beyond IT, the company operates a separate biotech division researching vaccines and antibiotics, and a real-estate management division run through a subsidiary. CreoSG is listed on KOSDAQ, South Korea's tech and small-cap exchange.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$7.9M

▲ +33.2% YoY

Operating profit · FY2025

−US$4.6M

Loss widened

Net income · FY2025

−US$6.2M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$7.1M(₩9.8B)	US$5.9M(₩8.2B)	US$7.9M(₩10.9B)
Operating profit	−US$2.7M(−₩3.7B)	−US$4.1M(−₩5.7B)	−US$4.6M(−₩6.4B)
Net income	−US$9.8M(−₩13.5B)	−US$10.1M(−₩13.9B)	−US$6.2M(−₩8.5B)

Revenue

FY2023US$7.1M
FY2024US$5.9M
FY2025US$7.9M

Operating profit

FY2023−US$2.7M
FY2024−US$4.1M
FY2025−US$4.6M

Net income

FY2023−US$9.8M
FY2024−US$10.1M
FY2025−US$6.2M

Key ratios (FY2025)

ROE

-18.1%

Debt/Eq

88.3%

Op. margin

-59.0%

Net margin

-78.7%

Rev. YoY

▲ +33.2%

Why it matters

CreoSG operates across three distinct divisions, IT solutions, biotech, and real-estate, through a parent-and-subsidiary structure, with the real-estate arm run via a subsidiary called CreoS Estate.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?